Table 4.

Measurements Used to Assess the Management of Chronic Diseases

	Residents	Attendings	P Value
Diabetics requiring treatment with oral agents/insulin, n	585	371
Mean number of hemoglobin A1c levels ordered	2.5	3.0	.0002
One or more ophthalmology consults ordered,%	30.6	12.6	.0001
Podiatry consult ordered, %	6.5	4.6	ns
One or more diabetic teaching consults ordered, %	11.3	7.3	ns
Admitted for any reason, %	19.3	18.1	ns
Admission for diabetic control, %	2.4	0.3	.04
Admission for cellulitis, %	1.4	0.3	ns
Asthma/COPD management, n	791	580
Inhaled beta agonists ordered, %	52.8	36.9	.0001
Inhaled steroids ordered, %	19.1	14.5	ns
Oral steroids ordered, %	6.5	5.7	ns
Admitted for any reason, %	15.3	10.4	.01
Hospital admission for asthma, %	3.9	1.4	ns
Congestive heart failure, n	50	62
ACE inhibitors ordered, %	78.0	64.5	ns
Admitted for any reason, %	50.0	27.4	ns
Admitted for congestive heart failure, %	16.0	9.7	ns
Ischemic heart disease, n	475	449
Beta blockers ordered, %	33.9	29.2	ns
Admitted for any reason, %	24.8	16.5	.01
Admitted for acute myocardial infarction, %	5.1	2.5	ns
Depression, n	522	370
Antidepressants ordered, %	45.4	51.1	ns
Admitted for any reason, %	13.0	10.5	ns
Admissions for depression, %	0.4	0.3	ns

Controlling for age, gender, insurance status, comorbidity, and specific illnesses that differed between resident and attending patients as shown in Table 1 (hypertension, diabetes, peptic ulcer disease, asthma, depression, dementia, and skin ulcers/cellulitis).

All measurements are taken over a 1-year period.

COPD, chronic obstructive pulmonary disease; ACE inhibitor, angiotensin-converting enzyme inhibitor; ns, not significant.